Abstract
Microinjection of either m̈ ‐ or ð‐ opioid agonists into the nucleus accumbens produces an increased locomotor activity, and when the dopaminergic innervation of the nucleus accumbens is bilaterally lesioned, the locomotor response to the microinjection of mixed m̈‐ and ð‐opioid is augmented. To determine whether the lesion‐induced augmentation to opioids is specific to m̈‐ or ð‐ opioid receptor activation, dopamine innervation of the nucleus accumbens was lesioned with 6‐hydroxydopamine (6‐OHDA), and the motor stimulant response to intra‐accumbens microinjection of the selective m̈‐ opioid agonist, Tyr‐D‐Ala‐Gly‐mePhe‐Gly‐OH (DAMGO), was compared to that of the ð‐opioid agonist, [D‐penicillamine2.5]‐enkephalin (DPDPE). The lesions caused a 95% depletion of tissue dopamine levels in the nucleus accumbens of the DAMGO‐injected rats compared to sham‐lesioned rats. Horizontal and vertical photocell counts were significantly increased in response to DAMGO in 6‐OHDA‐lesioned compared to the sham‐lesioned rats. This behavioral augmentation was dose dependent and blocked by naloxone. In rats with similar accumbal dopamine depletions (94%), the locomotor response to DPDPE was not enhanced. The augmentation in the behavioral response to DAMGO was not associated with a change in the Bmax or Kd of [125I] DAMGO binding in nucleus accumbens homogenates form lesioned rats. Likewise, using quantitative receptor autoradiography, no difference between 6‐OHDA‐ and sham‐lesioned rats was observed in [125I]DAMGO or [125I]DPDPE binding. Therefore, the augmented behavioral response to opioids in the nucleus accumbens following dopamine depletion relies predominately on ð‐opioid receptor stimulation. However, this augmentation is not mediated by an alteration in the number or affinity of these receptors. © Wiley‐Liss, Inc.

This publication has 49 references indexed in Scilit: